Annual Report

The report describes a strong 2014, with net sales and net profit growing 26.8% and 23.4%, respectively. The company introduced 27 new formulations during the year. Its CSR disclosures include employee healthcare and community support, with total CSR expenditure reported at Taka 45,949,055.